MedTrace Logo

Effect of Premeal Protein-bar on Glycemic Control in Patients With Type 2 Diabetes

NCT03727854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-04-13

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate the effect of premeal protein-enriched bar in long-term glycemic control in patients with type 2 diabetes mellitus. Glucose levels in subjects who intake premeal protein-enriched bar with dietary modification will be compared to those in subjects who only do the dietary modification.

Conditions

  • Patients With Type 2 Diabetes

Interventions

DIETARY_SUPPLEMENT

Premeal protein enriched bar

Subjects in the intervention group will intake protein enriched bar 15 minutes before each meals (at least twice a day).

BEHAVIORAL

Dietary modification

Subjects in this group will follow diabetes diet education.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Young Min Cho, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-27
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03727854 on ClinicalTrials.gov